FOSUN HEALTH Logo

Neuromyelitis Optica (NMO) Diagnosis

catalogue

Neuromyelitis Optica (NMO) Diagnosis

Neuromyelitis Optica (NMO) Diagnosis

The diagnosis here hangs on a blood test, and the single most useful thing a family can discover is whether that test was ever sent. The aquaporin-4 antibody, measured on serum by a cell-based assay, names the condition in most people who have it; where it is negative, the MOG antibody is the next question and a stricter combination of clinical and imaging features is required. What the diagnosis does not use is the multiple sclerosis criteria — dissemination in space and in time is not what is being shown here, and oligoclonal bands are absent in most people with this condition. What carries the weight on imaging is the cord, not the brain: a lesion running lengthwise across three or more vertebral segments. This page sets out what each test establishes and what it does not, why a single negative antibody does not close the question, and what a finished assessment should leave behind in writing.

The antibody, and where to test for it

The test that names this condition is drawn from a vein, not by lumbar puncture. It looks for an antibody against aquaporin-4 — the water channel on the surface of the astrocyte — and it is read by a cell-based assay rather than by older methods. That distinction is not pedantry: the assay determines whether a negative result means anything.

Three things follow from that, and they are the three reasons a file can contain a negative result and a positive disease at the same time. The first is the assay: cell-based assays detect the antibody in people that older techniques miss. The second is the timing: the level is generally higher during or near an attack, and lower between them. The third is treatment: immunosuppression can reduce or remove a detectable antibody, which is why a result drawn after treatment has begun is read differently from one drawn before.

Where the aquaporin-4 antibody is negative and the clinical picture fits, the MOG antibody is the next question. MOG antibody disease is a different condition with a different course — attacks that are often more steroid-responsive and a lower tendency to relapse — and naming it changes what a person is told as well as what they are given.

What should be said about the rare case where both are negative: the diagnosis is still available, but it requires a stricter combination of clinical features and imaging findings, and the antibody is worth repeating during a relapse rather than on a calendar. A file that says demyelinating disease with no antibody result at all is not a file in which the question was answered. It is a file in which it was never asked.

What imaging establishes

In this condition the brain scan is frequently the least informative part of the workup, and that is worth saying plainly because it is the opposite of what most people expect. The brain may be normal. It may show change that does not satisfy the multiple sclerosis criteria. Where it does show lesions, they tend to be larger and to sit in different places than the small scattered periventricular lesions of multiple sclerosis.

What carries the diagnostic weight is the cord, imaged with contrast and reported on its length rather than on its presence: a lesion spanning three or more vertebral segments is characteristic of this condition and unusual in multiple sclerosis. The second study that earns its place is the orbits with contrast, where the presentation is visual — showing involvement of the optic nerve and, importantly, how far along the nerve the signal runs, which correlates with how much vision comes back.

Study What it establishes What it does not do
Cord MRI with contrast A longitudinally extensive lesion — the finding that most cleanly separates this condition from multiple sclerosis Not seen at all where only the brain is imaged, which is the commonest technical omission in this workup
Brain MRI Excludes a great deal, and shows the patterns that do not belong to multiple sclerosis Not the study that makes the diagnosis. A normal brain scan is entirely compatible with this condition
Orbital MRI with contrast Involvement of the optic nerve and its extent, during an acute visual attack Not always abnormal later. An optic neuritis from years ago can leave the nerve looking unremarkable
A repeat study, compared against the previous one Whether anything is new, and whether a lesion has shortened or resolved after treatment Not a substitute for the antibody. A scan that changes without an antibody result still has the decisive question open

One practical instruction, because it is the one most often not carried out: image the cord. A workup of a myelitis that images the head and not the cord has not been completed, whatever the report says.

What the spinal fluid adds

The puncture has two jobs here, and neither of them is to make the diagnosis. The first is exclusion: infection and other inflammatory conditions are looked for, and that is work that cannot be done from a scan. The second is description: during an attack the cell count and protein are often raised, sometimes substantially, with a pattern that differs from the picture in multiple sclerosis.

The finding people ask about is the oligoclonal bands, and here the useful fact is a negative one: they are absent in most people with this condition, whereas they are present in most people with multiple sclerosis. That makes them useful in both directions, and it is worth knowing which direction a given result points. Where bands are present in someone being considered for this diagnosis, the reasonable response is to ask the multiple sclerosis question again rather than to settle this one.

What the fluid does not do is exclude the condition. A normal fluid, or one without bands, is entirely compatible with aquaporin-4-positive disease, and reading it as a negative answer is one of the ways this diagnosis is delayed.

What else has to be excluded by name

Alongside demonstrating what is there, the workup has to exclude what looks like it, and several of these have to be excluded by name rather than by impression.

Condition What excludes it, or points to it
Multiple sclerosis A negative aquaporin-4 antibody, short rather than longitudinal cord lesions, and oligoclonal bands — which are present in most people with MS and absent in most people here
MOG antibody disease The MOG antibody on serum. A different condition with a different course rather than a subtype of this one
Compressive or structural cord disease Imaging of the cord and of the spine around it. The commonest reason a cord attack is missed in someone over fifty
Infective myelitis Fever, the cell count and its pattern, and the infectious screens that belong in the workup rather than as an optional addition
Other autoimmune disease The autoimmune screen, including the thyroid and lupus antibodies that travel with this condition more often than chance would suggest
Nutritional and metabolic causes Vitamin B12 and the rest of the metabolic panel, which are cheap, quick, and regularly omitted
Vascular causes The pace of onset and the vascular imaging, where a deficit that was maximal in minutes is on the table

The principle that governs all seven: a differential that was considered but not tested is not an exclusion. A file that lists the alternatives in prose and tests none of them has done half the work.

Why the multiple sclerosis criteria do not apply

The multiple sclerosis diagnosis is built on showing dissemination — damage in more than one place, at more than one time. That is not what is being shown here. This condition is named by an antibody and by a clinical syndrome, and a single attack in someone with a positive aquaporin-4 antibody is enough, without waiting for a second one.

Three consequences follow, and all three are practical. The first is that waiting for a second attack is not required and is not safe: in a condition where disability is made of attacks, deferring the name until the second one means deferring the treatment that prevents it. The second is that the imaging criteria that were built for multiple sclerosis can be satisfied by this condition and can also be failed by it, which is why a normal brain scan does not argue against the diagnosis. The third is the one that matters most: the treatments are not interchangeable, and several multiple sclerosis agents are associated with worse outcomes here.

What a clinician should therefore be able to say is not "this meets criteria" but "this is aquaporin-4-positive disease, and here is what that changes about the treatment." That sentence is the diagnosis, and it is worth asking for in writing.

What a finished assessment leaves behind in writing

Five things, and a family is entitled to ask for each of them.

First, the antibody result, naming the assay — which antibody, on what specimen, by what method. Second, what the imaging showed and which regions were imaged, so that a reader can tell whether the cord was included and whether contrast was given. Third, which alternatives have been excluded and on what grounds, naming multiple sclerosis and MOG antibody disease specifically. Fourth, what would change the answer, including whether a repeat antibody during a relapse is the right next step. Fifth, what the follow-up has to contain: how often imaging is repeated and why, what is measured at each visit, and what finding would prompt a change in treatment.

That last item is the one most often left out, and in this condition it is the one that matters most — because the whole of the long-term question is whether the next attack is prevented, and that is answered by measurements taken between attacks rather than by anything said during one.

Frequently Asked Questions

Is it a blood test or a lumbar puncture?

A blood test. The aquaporin-4 antibody is measured on serum, by a cell-based assay, and it is the result that names the condition in most people who have it. The lumbar puncture has a different job here: excluding infection and other inflammation, and looking at the cell count and protein during an attack. Oligoclonal bands — the finding that supports multiple sclerosis — are absent in most people with this condition, which means their presence is a reason to ask the multiple sclerosis question again rather than a reason to settle this one.

My antibody was negative. Does that rule it out?

No, and this is one of the most consequential negative results in neurology to read carelessly. The assay matters: cell-based assays perform differently from older methods, and a negative result on one is not a negative result everywhere. The timing matters: the level can be lower between attacks. Treatment matters: immunosuppression can suppress the antibody. Where the clinical picture fits and the result was negative, repeating it during a relapse, on a cell-based assay, is the reasonable next step rather than closing the question.

Why does everyone keep comparing it to multiple sclerosis?

Because the two present in the same way and are managed differently, and because the error runs in one direction that is expensive. Several of the medicines used to treat multiple sclerosis — including some of the most effective ones — are associated with worse outcomes in aquaporin-4-positive disease rather than better ones. That is why the antibody test is asked for before a treatment is started rather than after, and why a diagnosis of multiple sclerosis made without it is worth revisiting.

How long does the diagnosis take?

The antibody result is the rate-limiting step and it is measured in days to weeks rather than minutes, which is why treatment for an attack is started on the clinical picture rather than waiting for it. Where the result is negative and the picture fits, the question can stay open for a long time — and what keeps it from becoming years is a repeat during a relapse rather than a repeat on a calendar. In this condition a name given late is a name given after attacks that could have been prevented, which is the cost that matters.

Find out whether the decisive test was ever sent, and what would answer the question

Send the imaging with its reports — brain, cord and orbits, in date order — any spinal fluid result with its date, and the list of antibody tests that were performed, including the assay used. Our team will return a written opinion on whether the diagnosis is secure, which alternatives have been excluded and on what grounds, and what is worth testing next, before any travel is arranged.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*